India to Hungary: Amlodipine Export Trade Route
India has recorded 46 verified shipments of Amlodipine exported to Hungary, representing a combined trade value of $67.3M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $1.5M USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 100% of total export value with 34 shipments worth $67.2M USD. On the buying side, MYLAN HUNGARY KFT, is the largest importer in Hungary with $66.6M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED , WATSON PHARMA PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Hungary Amlodipine corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $67.3M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $1.5M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 30.7%, placing it at rank #16 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in Hungary include MYLAN HUNGARY KFT,, MYLAN HUNGARY KFT, Mylan Hungary Kft and 10 others. MYLAN HUNGARY KFT, is the single largest importer with 12 shipments valued at $66.6M USD.
